In this study a new contrast agent consisting of a fluorescently labeled Affibody molecule that binds to the epidermal growth factor receptor (EGFR) was examined for uptake in orthotopic glioma tumors to assess the contrast available to guide surgery. Here, EGFR is linked to glioma.